Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Liver Diseases

Free Subscription Articles published in Ann Intern Med Retrieve available abstracts of 14 articles: HTML format

Single Articles

September 2025
1. IMPERIALE TF
   In MASH with moderate or advanced liver fibrosis, weekly semaglutide improved histologic steatohepatitis and fibrosis at 72 wk.
   Ann Intern Med. 2025 Sep 2. doi: 10.7326/ANNALS-25-03308.
   PubMed     Abstract available
   
   
   
2. KIM GA, Lim YS
   Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B.
   Ann Intern Med. 2025;178:1365-1366.
   PubMed    
   
   
   
3. HUANG SC, Kao JH
   Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B.
   Ann Intern Med. 2025;178:1364.
   PubMed    
   
   
   
4. WANG J, Pan Y, Fan T, Wu C, et al
   Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B.
   Ann Intern Med. 2025;178:1364-1365.
   PubMed    
   
   
   April 2025
5. CINTOSUN A, Jamal I, Samnani S, Song YN, et al
   Gastroenterology/Hepatology: What You May Have Missed in 2024.
   Ann Intern Med. 2025 Apr 1. doi: 10.7326/ANNALS-25-00959.
   PubMed     Abstract available
   
   
   February 2025
6. PALMER WC, Stancampiano FF
   Hemochromatosis.
   Ann Intern Med. 2025 Feb 11. doi: 10.7326/ANNALS-24-03710.
   PubMed     Abstract available
   
   
   January 2025
7. ALI SMJ, Lai M
   Metabolic Dysfunction-Associated Steatotic Liver Disease.
   Ann Intern Med. 2025;178:ITC1-ITC16.
   PubMed     Abstract available
   
   
   October 2024
8. KORULA J
   In adults with metabolic dysfunction, the MAF-5 score predicted risk for liver fibrosis (AUC range, 0.73 to 0.81).
   Ann Intern Med. 2024;177:JC119.
   PubMed     Abstract available
   
   
   September 2024
9. YANG JD, Kamath PS
   Revised REACH-B Model for Hepatocellular Carcinoma Risk Prediction in Patients With Chronic Hepatitis B.
   Ann Intern Med. 2024 Sep 17. doi: 10.7326/M24-0894.
   PubMed    
   
   
   
10. KIM GA, Lim YS, Han S, Choi GH, et al
    Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B : A Multinational Study for the Development and External Validation of a New Prognostic Model.
    Ann Intern Med. 2024 Sep 17. doi: 10.7326/M24-0384.
    PubMed     Abstract available
    
    
    July 2024
11. SIMON TG, Singer DE, Zhang Y, Mastrorilli JM, et al
    Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study.
    Ann Intern Med. 2024 Jul 9. doi: 10.7326/M23-3067.
    PubMed     Abstract available
    
    
    June 2024
12. MIRONOVA M, Sherker AH
    In NASH with liver fibrosis, resmetirom improved NASH resolution and reduced fibrosis at 1 y.
    Ann Intern Med. 2024;177:JC63.
    PubMed     Abstract available
    
    
    April 2024
13. LAKE JE, Kitch DW, Kantor A, Muthupillai R, et al
    The Effect of Open-Label Semaglutide on Metabolic Dysfunction-Associated Steatotic Liver Disease in People With HIV.
    Ann Intern Med. 2024 Apr 30. doi: 10.7326/M23-3354.
    PubMed    
    
    
    
14. ANVARI S, Dadgar K, Galts C, Bretthauer M, et al
    Gastroenterology/Hepatology: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0505.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.